| Phase III study of surgery versus definitive concurrent chemoradiotherapy boost in patients with resectable stage IIIA (N2) and selected IIIB non–small-cell lung cancer after … WEE Eberhardt, C Pöttgen, TC Gauler, G Friedel, S Veit, V Heinrich, ... Journal of Clinical Oncology 33 (35), 4194-4201, 2015 | 361 | 2015 |
| Value of 18F-Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography in Non–Small-Cell Lung Cancer for Prediction of Pathologic … C Pöttgen, S Levegrün, D Theegarten, S Marnitz, S Grehl, R Pink, ... Clinical cancer research 12 (1), 97-106, 2006 | 284 | 2006 |
| Prophylactic cranial irradiation in locally advanced non–small-cell lung cancer after multimodality treatment: Long-term follow-up and investigations of late neuropsychologic … M Stuschke, W Eberhardt, C Pottgen, G Stamatis, H Wilke, G Stuben, ... Journal of clinical oncology 17 (9), 2700-2700, 1999 | 233 | 1999 |
| Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer S Welter, J Jacobs, T Krbek, C Poettgen, G Stamatis European journal of cardio-thoracic surgery 31 (2), 167-172, 2007 | 217 | 2007 |
| ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer U Nestle, D De Ruysscher, U Ricardi, X Geets, J Belderbos, C Pöttgen, ... Radiotherapy and oncology 127 (1), 1-5, 2018 | 182 | 2018 |
| Prophylactic cranial irradiation in operable stage IIIA non-small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial C Pöttgen, W Eberhardt, A Grannass, S Korfee, G Stüben, H Teschler, ... Journal of Clinical Oncology 25 (31), 4987-4992, 2007 | 173 | 2007 |
| gamma-H2AX foci formation in peripheral blood lymphocytes of tumor patients after local radiotherapy to different sites of the body: Dependence on the dose … A Sak, S Grehl, P Erichsen, M Engelhard, A Grannaß, S Levegrün, ... International journal of radiation biology 83 (10), 639-652, 2007 | 152 | 2007 |
| Radiotherapy versus surgery within multimodality protocols for esophageal cancer–a meta-analysis of the randomized trials C Pöttgen, M Stuschke Cancer treatment reviews 38 (6), 599-604, 2012 | 117 | 2012 |
| Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans M Stuschke, A Kaiser, C Pöttgen, W Lübcke, J Farr Radiotherapy and Oncology 104 (1), 45-51, 2012 | 106 | 2012 |
| Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus E Gkika, T Gauler, W Eberhardt, M Stahl, M Stuschke, C Pöttgen Diseases of the Esophagus 27 (7), 678-684, 2014 | 102 | 2014 |
| Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice G Stüben, O Thews, C Pöttgen, K Knühmann, P Vaupel, M Stuschke Journal of cancer research and clinical oncology 127, 346-350, 2001 | 101 | 2001 |
| Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour A Marra, W Eberhardt, C Pöttgen, D Theegarten, S Korfee, T Gauler, ... European Respiratory Journal 29 (1), 117-126, 2007 | 97 | 2007 |
| Erythropoietin restores the anemia-induced reduction in radiosensitivity of experimental human tumors in nude mice G Stüben, C Pöttgen, K Knühmann, K Schmidt, M Stuschke, O Thews, ... International Journal of Radiation Oncology* Biology* Physics 55 (5), 1358-1362, 2003 | 90 | 2003 |
| Definitive radiochemotherapy versus surgery within multimodality treatment in stage III non-small cell lung cancer (NSCLC)-a cumulative meta-analysis of the randomized evidence C Pöttgen, W Eberhardt, G Stamatis, M Stuschke Oncotarget 8 (25), 41670, 2017 | 80 | 2017 |
| Hyperfractionated accelerated radiation therapy (HART) of 70.6 Gy with concurrent 5-FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced head and neck cancer … V Budach, C Stromberger, C Poettgen, M Baumann, W Budach, ... International Journal of Radiation Oncology* Biology* Physics 91 (5), 916-924, 2015 | 70 | 2015 |
| Correlation of PET/CT findings and histopathology after neoadjuvant therapy in non-small cell lung cancer C Poettgen, D Theegarten, W Eberhardt, S Levegruen, T Gauler, T Krbek, ... Oncology 73 (5-6), 316-323, 2008 | 69 | 2008 |
| Surgery after multimodality treatment for non-small-cell lung cancer G Stamatis, W Eberhard, C Pöttgen Lung Cancer 45, S107-S112, 2004 | 63 | 2004 |
| Increased radiation-induced apoptosis and altered cell cycle progression of human lung cancer cell lines by antisense oligodeoxynucleotides targeting p53 and p21WAF1/CIP1 A Sak, R Wurm, B Elo, S Grehl, C Pöttgen, G Stüben, B Sinn, G Wolf, ... Cancer gene therapy 10 (12), 926-934, 2003 | 58 | 2003 |
| Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: potentiation by irradiation H Gong, C Pöttgen, G Stüben, W Havers, M Stuschke, L Schweigerer International journal of cancer 106 (5), 723-728, 2003 | 57 | 2003 |
| Impact of anemia prevention by recombinant human erythropoietin on the sensitivity of xenografted glioblastomas to fractionated irradiation G Stüben, O Thews, C Pöttgen, K Knühmann, H Sack, M Stuschke, ... | 56 | 2003 |
